BIFIDO Co. Ltd (KQ:238200) — Market Cap & Net Worth
Market Cap & Net Worth: BIFIDO Co. Ltd (238200)
BIFIDO Co. Ltd (KQ:238200) has a market capitalization of $14.55 Million (₩21.47 Billion) as of July 14, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26104 globally and #1952 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIFIDO Co. Ltd's stock price ₩2625.00 by its total outstanding shares 8180000 (8.18 Million). See BIFIDO Co. Ltd capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
BIFIDO Co. Ltd Market Cap History: 2026 to 2026
BIFIDO Co. Ltd's market capitalization history from 2026 to 2026. Data shows growth from $14.55 Million to $14.55 Million (0.00% CAGR).
Index Memberships
BIFIDO Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$224.31 Billion | 0.01% | #1055 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$224.31 Billion | 0.01% | #1055 of 1384 |
Weight: BIFIDO Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BIFIDO Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIFIDO Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 238200 by Market Capitalization
Companies near BIFIDO Co. Ltd in the global market cap rankings as of July 14, 2026.
Key companies related to BIFIDO Co. Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #83 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #89 globally with a market cap of $214.29 Billion USD ( CHF169.50 Billion CHF).
- Danone SA (PA:BN): Ranked #528 globally with a market cap of $51.26 Billion USD ( €43.85 Billion EUR).
- Danone SA (F:BSND): Ranked #703 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #83 | Nestlé S.A | F:NESM | $224.33 Billion | €89.80 |
| #89 | Nestle S.A. | SW:NESN | $214.29 Billion | CHF84.16 |
| #528 | Danone SA | PA:BN | $51.26 Billion | €72.20 |
| #703 | Danone SA | F:BSND | $39.05 Billion | €14.00 |
BIFIDO Co. Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, BIFIDO Co. Ltd's market cap moved from $14.55 Million to $ 14.55 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩14.55 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 14th, 2026 the market cap of BIFIDO Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.55 Million USD |
| MoneyControl | $14.55 Million USD |
| MarketWatch | $14.55 Million USD |
| marketcap.company | $14.55 Million USD |
| Reuters | $14.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BIFIDO Co. Ltd
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.